Intratumoral Cell Heterogeneity in Patient-Derived Glioblastoma Cell Lines Revealed by Single-Cell RNA-Sequencing

• Published in: International journal of molecular sciences Vol. 25; no. 15; p. 8472
• Main Authors: Arbatskiy, Mikhail, Balandin, Dmitriy, Churov, Alexey, Varachev, Vyacheslav, Nikolaeva, Eugenia, Mitrofanov, Alexei, Bekyashev, Ali, Tkacheva, Olga, Susova, Olga, Nasedkina, Tatiana
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.08.2024
• Subjects: Analysis; Brain; Brain Neoplasms - genetics; Brain Neoplasms - pathology; Cancer; Cell culture; Cell Line, Tumor; Chromosomes; Cloning; DNA Copy Number Variations; Genes; Genetic Heterogeneity; Genomes; Genomics; glioblastoma; Glioblastoma - genetics; Glioblastoma - pathology; Glioblastoma multiforme; Glioma; Humans; intratumor heterogeneity; Morphology; Mutation; patient-derived cell lines; Patients; RNA; RNA sequencing; Sequence Analysis, RNA - methods; Single-Cell Analysis - methods; single-cell RNA sequencing; Stem cells; Tumor Microenvironment - genetics; Tumors; Russia; single-cell RNA sequencing; intratumor heterogeneity; glioblastoma; patient-derived cell lines
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25158472

Glioblastoma cell lines derived from different patients are widely used in tumor biology research and drug screening. A key feature of glioblastoma is the high level of inter- and intratumor heterogeneity that accounts for treatment resistance. Our aim was to investigate whether intratumor heterogeneity is maintained in cell models. Single-cell RNA sequencing was used to investigate the cellular composition of a tumor sample and six patient-derived glioblastoma cell lines. Three cell lines preserved the mutational profile of the original tumor, whereas three others differed from their precursors. Copy-number variation analysis showed significantly rearranged genomes in all the cell lines and in the tumor sample. The tumor had the most complex cell composition, including cancer cells and microenvironmental cells. Cell lines with a conserved genome had less diverse cellularity, and during cultivation, a relative increase in the stem-cell-derived progenitors was noticed. Cell lines with genomes different from those of the primary tumors mainly contained neural progenitor cells and microenvironmental cells. The establishment of cell lines without the driver mutations that are intrinsic to the original tumors may be related to the selection of clones or cell populations during cultivation. Thus, patient-derived glioblastoma cell lines differ substantially in their cellular profile, which should be taken into account in translational studies.